亚洲国产成人久久77-亚洲国产成人久久99精品-亚洲国产成人久久精品hezyo-亚洲国产成人久久精品动漫-人妖hd-人妖ts在线,一本道高清DVD在线视频,2020亚洲永久精品导航,国产久久视频在线视频观看

當(dāng)前位置: 首頁 JCRQ4 期刊介紹(非官網(wǎng))
Case Reports In Oncological Medicine

Case Reports In Oncological MedicineSCIE

國際簡稱:CASE REP ONCOL MED  參考譯名:腫瘤醫(yī)學(xué)病例報(bào)告

  • JCR分區(qū)

    Q4

基本信息:
ISSN:2090-6706
E-ISSN:2090-6714
是否OA:開放
是否預(yù)警:否
出版信息:
出版地區(qū):United Kingdom
出版商:Hindawi Limited
出版語言:English
研究方向:ONCOLOGY
評(píng)價(jià)信息:
影響因子:0.6
發(fā)文數(shù)據(jù):
Gold OA文章占比:97.96%
研究類文章占比:80.00%
年發(fā)文量:10
英文簡介 期刊介紹 JCR分區(qū) 常見問題

英文簡介Case Reports In Oncological Medicine期刊介紹

Case Reports in Oncology Medicine is a peer-reviewed open access journal focused on the field of oncology. This magazine publishes case reports related to various cancers, aiming to provide a platform for clinical doctors, researchers, and healthcare professionals to share unique cases, rare disease manifestations, treatment challenges, and innovative therapies. These case reports help to enhance understanding of cancer biology, diagnosis, treatment, and management, while also guiding future clinical practice and research directions.

The journal emphasizes the educational significance and scientific contribution of cases, encourages submission of detailed case descriptions, comprehensive literature reviews, and in-depth discussions. In this way, the magazine not only promotes the dissemination of individual case knowledge, but also helps to build a broader oncology community, thereby improving the quality of patient care worldwide. The types of contributions accepted by the magazine include single case reports and case series, and research topics cover a wide range of fields such as breast cancer, lung cancer, gastrointestinal cancer, skin cancer, head and neck cancer, paediatric oncology, neurooncology, and urogenital cancer. These studies are of great significance for promoting clinical progress and personalized medicine in oncology.

期刊簡介Case Reports In Oncological Medicine期刊介紹

《Case Reports In Oncological Medicine》該刊近一年未被列入預(yù)警期刊名單,目前已被權(quán)威數(shù)據(jù)庫SCIE收錄,得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn):

  • 預(yù)計(jì)審稿時(shí)間: 16 Weeks
  • SCIE
  • 非預(yù)警

JCR分區(qū)Case Reports In Oncological Medicine JCR分區(qū)

2023-2024 年最新版
按JIF指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
學(xué)科:ONCOLOGY ESCI Q4 299 / 322

7.3%

按JCI指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
學(xué)科:ONCOLOGY ESCI Q4 298 / 322

7.61%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異,此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問題的。因此,JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū),這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

投稿常見問題